New Report Assesses Potential Multibillion-Dollar Global Liquid Biopsy Markets Out to 2020; Cell-Free DNA, Circulating Tumor Cells, and Exosomes Included; 15 Countries Detailed

A new report, entitled “LIQUID BIOPSY MARKETS Global Market Size, Strategies, and Forecasts 2015 to 2020,” is now available from Report Buyer ( Published in August 2015, the report is 213 pages long and was prepared by Howe Sound Research. The report suggests that "blood tests replace surgical biopsies to create a new multibillion dollar market opportunity.” The screening test opportunity is explored. The report suggests that new technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy, but has outstanding growth potential, the report producers claim. In fact, it has the biggest numbers we've seen in the Clinical Diagnostics space, the producers say. The impact on the health care industry is enormous, according to the study. The report forecasts the market size out to 2020. In addition the report looks at potential market sizes by country, by cancer, and by the three different opportunities: detection, management, and screening. This independent research will, the producers say, give you the facts to speak with authority. Circulating tumor cells? Cell-free DNA? Exosomes? Find out about the technology in readily understandable terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. The report includes detailed breakouts for 15 countries and 4 regions along, with specific breakouts for lung, breast, colorectal, prostate, and other cancers. All report data is available in Excel format on request.
Login Or Register To Read Full Story